A multisociety Delphi consensus statement on new fatty liver disease nomenclature-Reference-Cited by-同舟云学术

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Published:2024-01 Issue:1 Volume:29 Page:101133
ISSN:1665-2681
Container-title:Annals of Hepatology
language:en
Short-container-title:Annals of Hepatology

Author:

Rinella Mary E.,Lazarus Jeffrey V.,Ratziu Vlad,Francque Sven M.,Sanyal Arun J.,Kanwal Fasiha,Romero Diana,Abdelmalek Manal F.,Anstee Quentin M.,Arab Juan Pablo,Arrese Marco,Bataller Ramon,Beuers Ulrich,Boursier Jerome,Bugianesi Elisabetta,Byrne Christopher D.,Narro Graciela E. Castro,Chowdhury Abhijit,Cortez-Pinto Helena,Cryer Donna R.,Cusi Kenneth,El-Kassas Mohamed,Klein Samuel,Eskridge Wayne,Fan Jiangao,Gawrieh Samer,Guy Cynthia D.,Harrison Stephen A.,Kim Seung Up,Koot Bart G.,Korenjak Marko,Kowdley Kris V.,Lacaille Florence,Loomba Rohit,Mitchell-Thain Robert,Morgan Timothy R.,Powell Elisabeth E.,Roden Michael,Romero-Gómez Manuel,Silva Marcelo,Singh Shivaram Prasad,Sookoian Silvia C.,Spearman C. Wendy,Tiniakos Dina,Valenti Luca,Vos Miriam B.,Wong Vincent Wai-Sun,Xanthakos Stavra,Yilmaz Yusuf,Younossi Zobair,Hobbs Ansley,Villota-Rivas Marcela,Newsome Philip N.

Publisher

Elsevier BV

Subject

Hepatology,General Medicine

Reference34 articles.

1. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease;Ludwig;Mayo Clin Proc,1980

2. Design and validation of a histological scoring system for nonalcoholic fatty liver disease;Kleiner;Hepatology,2005

3. Nonalcoholic steatohepatitis (NASH): further expansion of this clinical entity?;Brunt;Liver,1999

4. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients;Bedossa;Hepatology,2012

5. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PCOS and common androgen abnormalities in adolescents;NASPAG Essentials of Pediatric & Adolescent Gynecology;2025

2. Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease;Annals of Hepatology;2024-11

3. NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors;Pharmacological Research;2024-10

4. Hepatic steatosis and not type 2 diabetes, body mass index, or hepatic fibrosis associates with hyperglucagonemia in individuals with steatotic liver disease;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-10-01

5. Small Bowel Therapies for Metabolic Disease and Obesity;Gastrointestinal Endoscopy Clinics of North America;2024-10